Navigation Links
MUSC's Hollings Cancer Center, Ralph H. Johnson VA Medical Center Partner on New TomoTherapy Treatment for Cancer Patients
Date:1/31/2008

Intensity Modulated Radiation Incorporates CT Imaging to Deliver

Exceptional Accuracy

CHARLESTON, S.C., Jan. 31 /PRNewswire/ -- The Ralph H. Johnson VA Medical Center and the Medical University of South Carolina's Hollings Cancer Center have partnered to bring TomoTherapy -- the latest in precision radiation therapy -- to cancer patients.

The TomoTherapy Hi-Art Treatment System is one of two available in South Carolina. The VA Medical Center and Hollings Cancer Center (HCC), both located in Charleston, S.C., collaborated to bring the advanced technology to patients because of its ability to target tumors of all sizes throughout the body with exceptional accuracy while minimizing damage to surrounding tissue.

"We are happy for the opportunity to partner with the VA to bring this technology to cancer patients," said Joseph Jenrette, M.D., Chair of MUSC's Department of Radiation Oncology. "We consider it the most important breakthrough in radiation therapy in the past few years. It provides the most accurate treatment available for some cancers."

"TomoTherapy offers the latest cancer treatment technology to veterans and citizens throughout the Lowcountry," said Ralph H. Johnson VA Medical Center Director John Barilich. "We are very pleased to bring this technology to South Carolina through our partnership."

TomoTherapy, currently used for tumors of the head and neck, brain, lung/chest wall, pancreas, lymph nodes, spine, prostate, abdomen, and rectum, augments sophisticated cancer treatment protocols both facilities offer. HCC continues to offer conventional radiation with the linear accelerator. Expert teams including physicians, physicists, and radiation therapists develop treatment protocols based on an individual patient's diagnosis.

TomoTherapy incorporates 3-D CT images to "paint" a tumor. A thin beam rotates 360-degrees around the body, delivering precise treatment while avoiding surrounding tissue and organs. The use of CT imaging allows treatment teams to evaluate the tumor daily and refine dosage as necessary, possibly leading to new treatment protocols in which patients receive stronger doses for fewer days. Typically, patients receiving radiation therapy, via TomoTherapy or conventional means, do so daily for 5-35 days. Physicians from both facilities are developing new protocols to enhance patients' quality of life. In addition, the new technology offers advanced training for residents and medical students in South Carolina and neighboring states.


'/>"/>
SOURCE Medical University of South Carolina
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Hollings Cancer Center Creates $1 Million Endowed Chair for Breast Cancer Research and Treatment with Gift from the Spaulding-Paolozzi Foundation
2. Dako Selects Axeda for Remote Monitoring, Reporting, and Software Management of Cancer Diagnostic System
3. BRCA1 mutation linked to breast cancer stem cells
4. Breast cancer diagnosis comes late for women in gentrifying neighborhoods
5. UCLA researchers discover biomarkers that predict lung cancer patient response to therapy
6. Millennium and Harvard Medical School Sign Cooperative Agreement for Research in Novel Field of Cancer Biology
7. Study reveals improved prediction of prostrate cancer
8. Personality Traits Dont Affect Breast Cancer Risk
9. High-Dose Chemo Helps Beat Rare Brain Cancer
10. Molecules may help predict survival in liver cancer
11. Hutchinson Center Announces First Unclimbed Mountain to be Tackled by Big Expedition for Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... ... January 23, 2017 , ... The TouchPoint Solution, ... who entered metrics into the product’s app. The data replicates and validates ... that within just 30 seconds of using Buzzies, people experienced a 74 percent ...
(Date:1/24/2017)... Michigan (PRWEB) , ... January 24, 2017 , ... The ... other advocates for drug and alcohol awareness, have worked with communities to designate the ... year, observed January 23-29, 2017, the theme is “Shatter the Myths.” As a ...
(Date:1/23/2017)... ... January 23, 2017 , ... ... localization services for life science companies, has achieved ISO 17100:2015 certification following ... America. ISO 17100 is the globally recognized standard that establishes guidance for ...
(Date:1/23/2017)... ... 23, 2017 , ... The iaedp Foundation, recognized for its ... who treat the full spectrum of eating disorder problems, proudly announces the addition ... of the leading eating disorder treatments centers located throughout the U.S. As partners ...
(Date:1/23/2017)... ... 2017 , ... Sharon Kleyne, America’s leading water researcher, advocate and feared enemy ... of making new water infrastructure a number one priority. “As we usher in a ... infrastructure to become a top priority of our new political change agents.” Kleyne pointed ...
Breaking Medicine News(10 mins):
(Date:1/24/2017)... 23, 2017 ArisGlobal, a leading ... announces agClinical 3.3, the latest version of its comprehensive ... science organizations to confidently and efficiently meet new compliance ... the electronic trial master file so that compliance is ... ...
(Date:1/23/2017)... 2017  HOPE BIOSCIENCES announced today that it ... commercialize nuc -gemcitabine™ (APTA-12/HOPE-888) through a licensing ... nuc -Gemcitabine consists of Antisoma,s ... found on many cancer cells, and dFdCMP, an ... conjugates) or SMDCs (small molecule drug conjugates), which ...
(Date:1/23/2017)... 23, 2017  Therabron Therapeutics, Inc., a clinical-stage ... in respiratory care, today announced that the European ... has granted Orphan Drug Designation for Therabron,s CG367 ... Syndrome (BOS).  "We are pleased to ... to treat patients diagnosed with BOS following lung ...
Breaking Medicine Technology: